NUVB
Nuvation Bio·NYSE
--
--(--)
--
--(--)
7.92 / 10
Outperform
Analyst consensus is a Buy (100% from Wedbush) and sentiment is Outperform. Fund‑flow score 8.06 shows strong positive inflows across all size segments. Combined, the outlook remains highly favorable.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-27
InstitutionWedbush
Times predicted6
Historical Win Rate50.0%
Is money flowing into or out of NUVB?
- NUVB holds a Bullish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.92/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
